Results

Total Results: 101 records

Showing results for "low".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - Services HIT Health Information Technology HL7 Health Level 7 IT Information Technology LDL Low-Density
  2. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value
  3. cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG_v2.pdf
    June 16, 2020 - Version 1.0 June 16, 2020 For some conditions, like some cancers, the risk increases even at very low … same 10 questions developed by WHO, adjusted for the standard U.S. drink size of 14 grams and U.S. low-risk … The Quality Improvement department at Premier discovered their organization had very low scores on a … The CAGE questionnaire has been shown to have low sensitivity for pregnant women (Moyer, 2013), and … response to Question #1 The USAUDIT states, “because patients who do not drink above recommended low-risk
  4. cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG%20V3.pdf
    June 16, 2020 - Version 1.0 June 16, 2020 For some conditions, like some cancers, the risk increases even at very low … same 10 questions developed by WHO, adjusted for the standard U.S. drink size of 14 grams and U.S. low-risk … The Quality Improvement department at Premier discovered their organization had very low scores on a … The CAGE questionnaire has been shown to have low sensitivity for pregnant women (Moyer, 2013), and … response to Question #1 The USAUDIT states, “because patients who do not drink above recommended low-risk
  5. cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Pilot_Report_October_2022_508.pdf
    January 01, 2022 - into an application; the developer responsible for that integration reported needing to invest only a low … • The AAFP developer required a relatively low level of effort and resources to develop a successful
  6. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - Identified patients should consider using low- to moderate-dose statins for the prevention of CVD events … diabetes, which are poorly controlled despite taking medications for both, in addition to high levels of low … Bravo is 52 years old with low high-density lipoprotein cholesterol (HDL-C) and high LDL-C levels (as
  7. cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
    March 01, 2018 - clinical artifacts piloted; the leadership of AHRQ who championed the real-world use of CDS in a rural, low … , Pregnancy, Breastfeeding, Familial Hypercholesterolemia, and Hypertension). 2) Medications (i.e., Low
  8. cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2023 - diabetes which are poorly controlled despite taking medications for both in addition to high levels of low … Echo is 52 years old with low high-density lipoprotein cholesterol (HDL-C) and high LDL-C levels (as
  9. cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - Department of Health and Human Services HL7 Health Level 7 IT Information Technology LDL Low-Density
  10. cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - Department of Health and Human Services HL7 Health Level 7 IT Information Technology LDL Low-Density
  11. cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - Data-driven screening: The recommendations could change when relevant data change (e.g., new results for low
  12. cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
    January 01, 2010 - • Their impact on key parameters, such as low-density lipoprotein (LDL) cholesterol and systolic
  13. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
    April 01, 2021 - Data-driven screening: The recommendations could change when relevant data change (e.g., new results for low
  14. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdf
    September 01, 2022 - Data-driven screening: The recommendations could change when relevant data change (e.g., new results for low
  15. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdf
    September 01, 2022 - Data-driven screening: The recommendations could change when relevant data change (e.g., new results for low
  16. cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2023 - Data-driven screening: The recommendations could change when relevant data change (e.g., new results for low
  17. cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2017.pdf
    January 01, 2017 - using the CDS authoring tool, developers can ensure consistency across CDS artifacts with relatively low
  18. cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
    September 01, 2018 - As expected, the count of non-pharmacologic treatments is relatively low due to the lack of structured
  19. cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact_Updated%20Nov%202019.pdf
    November 01, 2019 - Data-driven screening: The recommendations could change when relevant data changes, including new low
  20. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
    January 01, 2003 - with panic disorder 104122 Sulfasalazine 30 MG/ML Enema 197901 Lorazepam 1 MG Oral Tablet M54.5 Low

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: